Results 101 to 110 of about 17,749 (168)

Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study. [PDF]

Hum Vaccin Immunother
Villagomez-Martinez S, Kharit S, Galustyan A, Zambrano B, Singh Dhingra M, B'Chir S, Syrkina O, Lyabis O, Rehm C.   +8 more
europepmc   +1 more source

Tetanus Toxoid Vaccination Coverage and Associated Factors among Childbearing Women in Ethiopia: A Systematic Review and Meta-Analysis. [PDF]

Biomed Res Int, 2021
Nigussie J, Girma B, Molla A, Mareg M.
europepmc   +1 more source

Overuse of tetanus toxoid vaccine: a common but under-addressed issue in Nepal. [PDF]

Ann Med Surg (Lond)
Shrestha S, Aryal R, Yadav RS, Baidya S, Acharya S, Bhandari SS.   +5 more
europepmc   +1 more source

Investigation of Cysteine Modifications in Recombinant Protein Tetanus Toxoid Heavy Chain Fragment C. [PDF]

J Am Soc Mass Spectrom, 2021
Cai CX, Schneck NA, Cozine T, Ivleva VB, Ragheb D, Gollapudi D, Patel A, Barefoot N, Gowetski DB, Lei QP.   +9 more
europepmc   +1 more source

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age. [PDF]

Hum Vaccin Immunother, 2022
Marshall GS, Pelton SI, Robertson CA, Oster P.   +3 more
europepmc   +1 more source

Factors associated with tetanus toxoid vaccine utilization among reproductive-age women in Debre Markos town, Ethiopia, 2021: a cross-sectional study. [PDF]

Ther Adv Vaccines Immunother
Tamiru YD, Sendo EG, Deressa JT.
europepmc   +1 more source

A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen. [PDF]

NPJ Vaccines, 2021
Ticha O, Klemm D, Moos L, Bekeredjian-Ding I.   +3 more
europepmc   +1 more source

Suspected Diphtheria Toxoid and Tetanus Toxoid (dTdap) Booster Vaccine-Induced Postural Orthostatic Tachycardia Syndrome (POTS). [PDF]

Cureus
Katwaroo AR, Chandolu KM, Seecheran VK, Ramcharan P, Seecheran RV, Giddings S, Bhagwandass N, Seecheran NA.   +7 more
europepmc   +1 more source

Uptake of protective tetanus toxoid vaccine doses and maternal associated factors during pregnancy in armed conflict zone, hospital-based cross-sectional study. [PDF]

Front Reprod Health
Kebede Bizuneh F, Muhidin Mustofa S.
europepmc   +1 more source

Impact of the US Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccination Program on Preventing Pertussis in Infants 2 to <6 Months of Age: A Case-Control Evaluation. [PDF]

Open Forum Infect Dis
Skoff TH, Rubis AB, Kirley PD, Scherzinger K, McMahon M, McGuire S, Kudish K, Cieslak PR, Shang N, Hariri S.   +9 more
europepmc   +1 more source